[1]王云检,张　珉,张　玲,等.原发性肝癌非根治性切除术中肝断面处理方法研究[J].新乡医学院学报,2019,36(8):732-735.[doi:10.7683/xxyxyxb.2019.08.007]
　WANG Yun-jian,ZHANG Min,ZHANG Ling,et al.Study on the treatment of residue liver in non-radical hepatectomy of primary liver cancer[J].Journal of Xinxiang Medical University,2019,36(8):732-735.[doi:10.7683/xxyxyxb.2019.08.007]
点击复制

原发性肝癌非根治性切除术中肝断面处理方法研究
分享到：

《新乡医学院学报》[ISSN:1004-7239/CN:41-1186/R]

卷:
36
期数:
2019年8
页码:
732-735
栏目:
临床研究
出版日期:
2019-08-05

文章信息/Info

Title:
Study on the treatment of residue liver in non-radical hepatectomy of primary liver cancer
作者:
王云检; 张　珉; 张　玲; 尤国华; 张璐阳
（郑州大学附属肿瘤医院肝胆外科，河南　郑州　450000）
Author(s):
WANG Yun-jian; ZHANG Min; ZHANG Ling; YOU Guo-hua; ZHAGN Lu-yang
(Department of Hepatobiliary Surgery,the Affiliated Tumor Hospital of Zhengzhou University,Zhengzhou 450000,Henan Province,China)
关键词:
原发性肝癌; 肝癌切除术; 肿瘤复发; 125I放射性粒子; 高频电刀; 植入用缓释氟尿嘧啶
Keywords:
primary liver cancer; hepatectomy; tumor recurrence; 125I radioactive particles; high frequency electrotome; fluorouracil sustained release for implant
分类号:
R735.7
DOI:
10.7683/xxyxyxb.2019.08.007
文献标志码:
A
摘要:
目的　探讨原发性肝癌（PLC）患者肝癌非根治性切除术中肝断面处理方法对术后复发的影响。方法　选择2013年1月至2015年12月郑州大学附属肿瘤医院收治的139例PLC患者为研究对象，所有患者行肝癌非根治性切除术，根据术中肝断面处理方法分为观察组和对照组。对照组38例患者术中肝断面只做结扎止血处理；观察组101例患者术中肝断面分别给予高频电刀烧灼（28例）、放置植入用缓释氟尿嘧啶（49例）、放置125I放射性粒子（24例）处理。分别于治疗前、治疗后检测患者血清丙氨酸转氨酶（ALT）、谷草转氨酶（AST）、尿素氮及全血白细胞（WBC）水平，观察2组患者术后引流量、住院时间及胆漏、腹腔出血、腹腔感染发生率；所有患者术后随访1 a，统计术后6个月、6～12个月内肿瘤复发率。结果　2组患者手术前后血清ALT、AST、尿素氮及WBC水平比较差异均无统计学意义（P>0.05）。观察组患者术后胆漏、腹腔出血及腹腔感染发生率分别为6.93%（7/101）、2.97%（3/101）、14.85%（15/101），对照组患者术后胆漏、腹腔出血及腹腔感染发生率分别为5.26%（2/38）、2.63%（1/38）、13.16%（5/38）；2组患者术后胆漏、腹腔出血及腹腔感染发生率比较差异均无统计学意义（χ2=0.126、0.011、0.064，P>0.05）。2组患者术后引流量及住院时间比较差异均无统计学意义（t=1.440、0.521，P>0.05）。观察组患者术后6个月、6～12个月肿瘤复发率分别为12.87%（13/101）、8.04%（7/87），对照组患者术后6个月、6～12个月肿瘤复发率分别为28.95%（11/38）、11.11%（3/27）；观察组患者术后6个月肿瘤复发率显著低于对照组（χ2=4.995，P<0.05），但2组患者术后6～12个月肿瘤复发率比较差异无统计学意义（χ2=0.242，P<0.05）。观察组患者中，术中肝断面高频电刀烧灼患者术后6个月、6～12个月肿瘤复发率分别为14.29%%（4/28）、12.50%（3/24），肝断面放置植入用缓释氟尿嘧啶患者术后6个月、6～12个月肿瘤复发率分别为12.24%（6/49）、6.98%（3/43），肝断面放置125I放射性粒子患者术后6个月、6～12个月肿瘤复发率分别为12.50%（3/24）、4.76%（1/21）；肝断面3种处理方法患者的术后6个月、6～12个月肿瘤复发率比较差异无统计学意义（χ2=0.965、1.026，P<0.05）。结论　肝癌切除术中因肿瘤较大、紧邻重要管系或肝功能较差等原因无足够的切缘时，肝断面应该进行必要的处理，肝断面高频电刀烧灼、放置植入用缓释氟尿嘧啶、放置125I放射性粒子可以明显降低肝癌术后短期复发率。
Abstract:
Objective　To investigate the effect of hepatic section treatment on the recurrence of primary liver cancer (PLC) after non-radical hepatectomy.Methods　A total of 139 patients with PLC admitted to the Affiliated Tumor Hospital of Zhengzhou University from January 2013 to December 2015 were selected as the study subjects.All patients underwent non-radical hepatectomy.They were divided into observation group and control group according to the intraoperative treatment of liver section.The 38 patients in the control group underwent only ligation and hemostasis of the liver section during operation.In the observation group,101 patients were treated with high frequency electric knife cauterization (28 cases),fluorouracil sustained release for implant (49 cases) and 125I radioactive particles (24 cases).The levels of serum alanine aminotransferase (ALT),aspartate aminotransferase (AST),urea nitrogen and whole blood cell (WBC) were measured before and after treatment.The postoperative drainage volume,hospitalization time,bile leakage,abdominal hemorrhage and incidence of abdominal infection were observed in the two groups.All patients were followed up for 1 year,and the tumor recurrence rate was calculated within 6 months and 6-12 months after operation.Results　There was no significant difference in the levels of serum ALT,AST,urea nitrogen and WBC between the two groups before and after operation (P>0.05).The incidences of bile leakage,abdominal hemorrhage and abdominal infection were 6.93% (7/101),2.97% (3/101) and 14.85% (15/101) in the observation group,and they were 5.26% (2/38),2.63% (1/38) and 13.16% (5/38) in the control group.There was no significant difference in the incidence of bile leakage,abdominal hemorrhage and abdominal infection between the two groups (χ2=0.126,0.011,0.064;P>0.05).There was no significant difference in postoperative drainage volume and hospitalization time between the two groups (t=1.440,0.521;P>0.05).The tumor recurrence rates in the observation group were 12.87% (13/101) and 8.04% (7/87) at 6 months and 6-12 months after operation,respectively;and they were 28.95% (11/38) and 11.11% (3/27) in the control group,respectively.The tumor recurrence rate in the observation group was significantly lower than that in the control group at 6 months after operation (χ2=4.995,P<0.05),but there was no significant difference between the two groups at 6-12 months after operation (χ2=0.242,P<0.05).In the observation group,the tumor recurrence rates of patients with high frequency electric knife cauterization were 14.29% (4/28) and 12.50% (3/24) at 6 months and 6-12 months after operation;and they were 12.24%(6/49) and 6.98%(3/43) in patients with fluorouracil sustained release for implant,and 12.50%(3/24) and 4.76%(1/21) in patients with 125I radioactive particles.There was no significant difference in the tumor recurrence rate at 6 months and 6-12 months after operation (χ2=0.965,1.026;P<0.05).Conclusion　When the resection margin of liver cancer is insufficient due to large tumors,adjacent important ducts or poor liver function and other reasons,the hepatic section should be treated as necessary.The high frequency electric knife cauterization,fluorouracil sustained release for implant and 125I radioactive particles can significantly reduced the short-term recurrence rate of liver cancer after operation.

参考文献/References:

［1］　BRAY F,FERLAY J,SOERJOMATARAM I,et al.Global cancer statistics 2018:GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries［J］.CA Cancer J Clin,2018,68(6):394-424.
［2］　ZHENG R S,QU C F,ZHANG S W,et al.Liver cancer incidence and mortality in China:temporal trends and projections to 2030［J］.Chin J Cancer Res,2018,30(6):571-579.
［3］　CHEN W,ZHENG R,BAADE P D,et al.Cancer statistics in China,2015［J］.CA Cancer J Clin,2016,66(2):115-132.
［4］　彭磷基，陆大祥.肝癌治疗学的研究进展［J］.中国老年学杂志，2009，29（5）：628-631.
［5］　中华医学会外科学分会肝脏外科学组.肝细胞癌外科治疗方法的选择专家共识：2016年第3次修订［J］.中华消化外科杂志，2017，16（2）：113-115.
［6］　TORRE L A,BRAY F,SIEGEL R L,et al.Global cancer statistics,2012［J］.CA Cancer J Clin,2015,65(2):87-108.
［7］　ALLEMANI C,WEIR H K,CARREIRA H,et al.Global sur-veillance of cancer survival 1995-2009:analysis of individual data for 25,676,887 patients from 279 population-based registries in 67 countries (CONCORD-2)［J］.Lancet,2015,385(9972):977-1010.
［8］　DE MARTEL C,MAUCORT-BOULCH D,PLUMMER M,et al.World-wide relative contribution of hepatitis B and C viruses in hepatocellular carcinoma［J］.Hepatology,2015,62(4):1190-1200.
［9］　ISLAMI F,CHEN W,YU X Q,et al.Cancer deaths and cases attributable to lifestyle factors and infections in China,2013［J］.Ann Oncol,2017,28(10):2567-2574.

相似文献/References:

[1]常旭,区庆嘉.干扰素α－2b对原发性肝癌切除及肝动脉栓塞术后T细胞亚群的影响 [J].新乡医学院学报,1995,12(04):337.
[2]冯献明,付方现,刘俊叶,等.艾迪注射液联合5-氟尿嘧啶加顺铂化疗方案治疗中晚期肝癌[J].新乡医学院学报,2010,27(03):273.
[3]张 辉,徐新保,何晓军,等.肝动脉栓塞化学治疗联合射频消融与再次手术切除治疗原发性肝癌术后复发的疗效比较[J].新乡医学院学报,2014,31(11):928.[doi:10.7683/xxyxyxb.2014.11.018]
[4]王政强,韩锋博.肝癌切除术联合肝动脉化疗栓塞术治疗中晚期肝癌疗效观察[J].新乡医学院学报,2021,38(10):957.[doi:10.7683/xxyxyxb.2021.10.012]
　WANG Zhengqiang,HAN Fengbo.Effect of hepatectomy combined with transcatheter hepatic arterial chemoembolization in the treatment of middle-advanced liver cancer[J].Journal of Xinxiang Medical University,2021,38(8):957.[doi:10.7683/xxyxyxb.2021.10.012]
[5]李　靖,肖金成,郑　琳,等.肝动脉栓塞化学治疗与肝动脉栓塞治疗原发性肝癌疗效比较[J].新乡医学院学报,2018,35(11):981.[doi:10.7683/xxyxyxb.2018.11.008]
　LI Jing,XIAO Jing-cheng,ZHENG Lin,et al.Comparison of the effect of transcatheter arterial embolization and transcatheter arterial chemoem-bolization in treatment of primary liver cancer[J].Journal of Xinxiang Medical University,2018,35(8):981.[doi:10.7683/xxyxyxb.2018.11.008]
[6]王　瑛,袁鹤立,张　博,等.肠内营养对行肝动脉化学治疗栓塞术原发性肝癌患者血清炎性因子及免疫细胞的影响[J].新乡医学院学报,2019,36(11):1064.[doi:10.7683/xxyxyxb.2019.11.014]
　WANG Ying,YUAN He-li,ZHANG Bo,et al.Effect of enteral nutrition on the levels of serum inflammatory factors and immune cells in patients with primary hepatocellular carcinoma after transcatheter arterial chemoembolization[J].Journal of Xinxiang Medical University,2019,36(8):1064.[doi:10.7683/xxyxyxb.2019.11.014]
[7]陈文换,杨峰燕,张艳华,等.原发性肝癌组织中微RNA-543表达与微血管密度的相关性[J].新乡医学院学报,2021,38(7):662.[doi:10.7683/xxyxyxb.2021.07.013]
　CHEN Wenhuan,YANG Fengyan,ZHANG Yanhua,et al.Correlation between microRNA-543 expression and microvessel density in primary liver cancer tissues[J].Journal of Xinxiang Medical University,2021,38(8):662.[doi:10.7683/xxyxyxb.2021.07.013]
[8]周世凤,詹　玮,边成富.右美托咪定对行肝叶切除术原发性肝癌患者氧化应激、肝功能及外周血单核细胞内Toll样受体2和Toll样受体4表达的影响[J].新乡医学院学报,2020,37(9):869.[doi:10.7683/xxyxyxb.2020.09.015]
　ZHOU Shifeng,ZHAN Wei,BIAN Chengfu.Effect of dexmedetomidine on oxidative stress，liver function and expression of Toll-like receptor 2 and Toll-like receptor 4 in peripheral blood monouclear cells in patients with primary liver cancer undergoing hepalobectomy[J].Journal of Xinxiang Medical University,2020,37(8):869.[doi:10.7683/xxyxyxb.2020.09.015]
[9]梁长华,毛华杰,梁　盼,等.原发性肝癌320排容积CT灌注参数值与肿瘤体积及肝功能Child-Pugh分级的相关性[J].新乡医学院学报,2018,35(1):065.[doi:10.7683/xxyxyxb.2018.01.016]
　LIANG Chang-hua,MAO Hua-jie,LIANG Pan,et al.Correlation between 320 row volume CT perfusion parameters of primary liver cancer and liver tumor volume and liver function Child-Pugh classification[J].Journal of Xinxiang Medical University,2018,35(8):065.[doi:10.7683/xxyxyxb.2018.01.016]
[10]王　雷,王煜霞,薛会朝.多药耐药相关蛋白在原发性肝癌患者外周血淋巴细胞及癌组织中的表达[J].新乡医学院学报,2017,34(6):538.[doi:10.7683/xxyxyxb.2017.06.024]
　WANG Lei,WANG Yu-xia,XUE Hui-chao.Expression of multidrug resistance related proteins of P-glycoprotein，lung resistance protein and glutathione S-transferase-π in peripheral blood lymphocytes and cancer tissues in patients with hepatocellular carcinoma[J].Journal of Xinxiang Medical University,2017,34(8):538.[doi:10.7683/xxyxyxb.2017.06.024]

更新日期/Last Update: 2019-08-05